// App-Quantinova.ai

EP01.01 : Prognostic value of maternal serum angiogenic markers for prediction of maternal adverse outcomes in women with pre-eclampsia

Researchers

Presenter

  • J. Binder

Principal Investigators

  • P. Palmrich

  • E. Kalafat

  • P. Pateisky

  • N. Schirwani

  • A. Khalil

Medical Centers

  • Obstetrics and Fetomaternal Medicine, Gynecology Clinic, Medical University of Vienna, Vienna, Austria

  • Obstetrics and Gynecology, Koc University Hospital, Istanbul, Turkey

  • Fetal Medicine Unit, St George's Hospital Medical School, University of London, London, United Kingdom

Locations

  • Austria

  • Turkey

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Preeclampsia

Biomarkers

  • Creatinine

  • Fms related tyrosine kinase 1

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved